Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. - Wikidata - awgldk - TriplyDB

Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.

Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.

http://www.wikidata.org/entity/Q34266381

about

DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation Facioscapulohumeral dystrophy: the path to consensus on pathophysiology Muscle lim protein isoform negatively regulates striated muscle actin dynamics and differentiation DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1 Muscle LIM protein interacts with cofilin 2 and regulates F-actin dynamics in cardiac and skeletal muscle Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy DNaseI hypersensitivity at gene-poor, FSH dystrophy-linked 4q35.2 Distinctive patterns of microRNA expression in primary muscular disorders A muscle stem cell for every muscle: variability of satellite cell biology among different muscle groups Reduced satellite cell numbers and myogenic capacity in aging can be alleviated by endurance exercise Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD)Deregulation of the protocadherin gene FAT1 alters muscle shapes: implications for the pathogenesis of facioscapulohumeral dystrophy Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation Rbfox1 downregulation and altered calpain 3 splicing by FRG1 in a mouse model of Facioscapulohumeral muscular dystrophy (FSHD)Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy SORBS2 transcription is activated by telomere position effect-over long distance upon telomere shortening in muscle cells from patients with facioscapulohumeral dystrophy β-Catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy.A functional role for 4qA/B in the structural rearrangement of the 4q35 region and in the regulation of FRG1 and ANT1 in facioscapulohumeral dystrophy.Gene expression profiling in limb-girdle muscular dystrophy 2A Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD).Biphasic myopathic phenotype of mouse DUX, an ORF within conserved FSHD-related repeats.Expression, tandem repeat copy number variation and stability of four macrosatellite arrays in the human genome.Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sites.Testing the effects of FSHD candidate gene expression in vertebrate muscle development.DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects Gene expression during normal and FSHD myogenesis.DNA replication timing is maintained genome-wide in primary human myoblasts independent of D4Z4 contraction in FSH muscular dystrophy A unique library of myogenic cells from facioscapulohumeral muscular dystrophy subjects and unaffected relatives: family, disease and cell function.DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle Muscular dystrophy candidate gene FRG1 is critical for muscle development.Next-generation sequencing analysis of miRNA expression in control and FSHD myogenesis.Dominant lethal pathologies in male mice engineered to contain an X-linked DUX4 transgene Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles.Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level.Drosophila melanogaster muscle LIM protein and alpha-actinin function together to stabilize muscle cytoarchitecture: a potential role for Mlp84B in actin-crosslinking.FSHD myotubes with different phenotypes exhibit distinct proteomes.

P2860

Q21091176-26B62B1E-0CE2-4A63-9696-2721F79910F2 Q21195884-2681686C-0093-4F24-9578-6F09FEABB059 Q24298282-0ADD5120-5FD3-4C7C-9D83-580B0356C434 Q24299685-E5CD5CFC-5ECB-4556-84C0-B604721DFAA8 Q24645285-A7934806-93E9-4165-BD74-D87E0C8CF520 Q24655776-017EAF3F-DC87-4B57-8914-003DA5CAA42E Q24657535-F2413369-418E-4762-8F37-C347718A7952 Q24675407-96E0A94B-CF6A-45D1-BD14-9A9921D8A344 Q26779289-47CC0151-252D-4BEF-BCDC-2EA8C3998F82 Q27318138-027685F6-321A-4487-8AD9-4BECB0D2C813 Q27318439-D618ECCD-58B0-4377-B47F-77CCE67B1E8E Q27322323-56CBD784-EA4C-4ADA-B8A7-5FD99C1950F7 Q28114835-47C30BAD-2C8E-4159-A510-2A28C9C0D132 Q28513387-E49796D0-EB2E-4AF2-B54F-B8B0D123AE9F Q28757194-19EABE9A-274C-439D-AC69-E8AEC750D2C6 Q29036117-75DA1236-329A-4062-8D57-449448A86698 Q30009101-728104C7-3E14-48EE-85BE-411EC080B43F Q30394383-5800C6DB-DC52-4B4B-9451-878CCA49D480 Q33375719-210B06BE-B8C9-4349-8ED3-17C365B5B9E6 Q33385149-341F5BAA-27CF-437B-98F0-411854EFE270 Q33480945-F8284873-CDC6-4A68-B0F4-1625A6FF3DD3 Q33503626-D116C9A6-6496-4558-9137-A2BDB0164887 Q33747006-9287FCED-50C0-4BCE-8330-237042CCDFE7 Q33748620-16DB09B2-8A71-453D-853F-361A8F5C6E2B Q33861089-C666F10F-40DD-412C-AF79-BE048D44511B Q33903001-13CAEB73-F9EA-41E5-9B42-C4633AE2AEE4 Q33938612-3FE2DEA5-BED5-4CA1-83D3-AD01D780B6DD Q33939411-EA5C76C2-9EE8-4F25-A7C5-58CFF87C4516 Q34022975-350E7A99-0275-4A46-AE28-0F1D95CB82B5 Q34032716-AA303279-E565-4426-ACFC-07FA32C9E653 Q34077893-C7892D4B-446A-4DDC-9F02-E37B9898CE0A Q34080484-E279A574-765D-40C0-9E65-23DB250315FA Q34211798-1A7257EB-D2DE-491B-AD08-5936A2256B62 Q34244856-8E0216E8-21D2-4AC8-AB52-C07720013E37 Q34294130-F6ED0AC4-AAAE-48AF-B0D2-115EE3E635B1 Q34300873-D58E930F-286A-496B-8B24-3FE614804D44 Q34311972-B160AC37-55A1-4729-A3C5-33AD332D2DBB Q34328093-1C83F564-6148-4459-87FC-5F3768846AAD Q34340665-F0670EA4-34CD-4137-907F-C0841F5C9DC0 Q34525765-C3E4074E-E7BF-474A-8DD6-3F96413344B9

P2860

Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.

http://www.wikidata.org/entity/Q34266381

description

2003 nî lūn-bûn

@nan

2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Expression profiling of FSHD m ...... s of myogenic differentiation.

@ast

Expression profiling of FSHD m ...... s of myogenic differentiation.

@en

Expression profiling of FSHD m ...... s of myogenic differentiation.

@nl

type

label

Expression profiling of FSHD m ...... s of myogenic differentiation.

@ast

Expression profiling of FSHD m ...... s of myogenic differentiation.

@en

Expression profiling of FSHD m ...... s of myogenic differentiation.

@nl

prefLabel

Expression profiling of FSHD m ...... s of myogenic differentiation.

@ast

Expression profiling of FSHD m ...... s of myogenic differentiation.

@en

Expression profiling of FSHD m ...... s of myogenic differentiation.

@nl

P1433

Q34266381-CF4C4CE3-3583-4D0E-BD45-2CD3AD919D58

P1476

Q34266381-BDE2ED16-0C2B-4076-9F62-8173331950AA

P2093

Q34266381-3800C335-928E-4CA2-ABD3-24F19A1149CB

Q34266381-519BBFAD-DC1A-4C5B-A0F7-DAFC4142947E

Q34266381-520BF4FF-2D10-41CB-B8EE-2156F1A03E8A

Q34266381-A47C7D5D-50ED-4313-8994-AE411A6C9B50

Q34266381-CF4C6295-2A35-4C52-AB9E-920DDA649658

Q34266381-DD279322-EB2D-4754-A7E8-8A3FCFBF3A5A

Q34266381-ECB9B113-5758-4EC0-8BBB-87AFBDAB8D20

P304

Q34266381-A35991EA-8337-481F-A8CC-C7172B4082C2

P31

Q34266381-3CF92048-0386-49F4-ADB9-CB3FB1A6EC5F

P356

Q34266381-7C713699-7121-42B8-8FEC-6652CBAB9767

P433

Q34266381-C5FFAC23-8AA5-456F-8C64-49C161353B4B

P478

Q34266381-6F3AC04F-460F-4084-875E-6091549878AF

P50

Q34266381-4F7FF5B9-F8F7-4DF1-B524-2C8771C0DD73

Q34266381-A1020376-3412-43C9-B1CC-EC30B5E33A04

P577

Q34266381-376016D1-1E7F-40FA-B7EC-F070DF300550

P5875

Q34266381-0497BC8B-A6C3-4E61-8463-88C424900DD0

P698

Q34266381-E46491BB-B8F5-4638-BD2E-DE211315E6C8

P356

P1433

Human Molecular Genetics

P1476

Expression profiling of FSHD m ...... es of myogenic differentiation

@en

P2093

Jeffrey T Ehmsen

http://www.w3.org/2001/XMLSchema#string

Jorge H Martin

http://www.w3.org/2001/XMLSchema#string

Peter S Masny

http://www.w3.org/2001/XMLSchema#string

Sara T Winokur

http://www.w3.org/2001/XMLSchema#string

Stephen J Tapscott

http://www.w3.org/2001/XMLSchema#string

Yi-Wen Chen

http://www.w3.org/2001/XMLSchema#string

Yukiko Hayashi

http://www.w3.org/2001/XMLSchema#string

P304

2895-2907

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDG327

http://www.w3.org/2001/XMLSchema#string

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Kevin M. Flanigan

Silvère M van der Maarel

P577

2003-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5606313

http://www.w3.org/2001/XMLSchema#string

P698

14519683

http://www.w3.org/2001/XMLSchema#string